The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies
Open accessAbstract
Background Body mass index (BMI), a measure of obesity typically assessed in middle age or later, is known to be positively associated with pancreatic cancer. However, little evidence exists regarding the influence of central adiposity, a high BMI during early adulthood, and weight gain after early adulthood on pancreatic cancer risk.Design We conducted a pooled analysis of individual-level data from 20 prospective cohort studies in the National Cancer Institute BMI and Mortality Cohort Consortium to examine the association of pancreatic cancer mortality with measures of central adiposity (e.g. waist circumference; n = 647 478; 1947 pancreatic cancer deaths), BMI during early adulthood (ages 18-21 years) and BMI change between early adulthood and cohort enrollment, mostly in middle age or later (n = 1 096 492; 3223 pancreatic cancer deaths). Multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using Cox proportional hazards regression models.Results Higher waist-to-hip ratio (HR = 1.09, 95% CI 1.02-1.17 per 0.1 increment) and waist circumference (HR = 1.07, 95% CI 1.00-1.14 per 10 cm) were associated with increased risk of pancreatic cancer mortality, even when adjusted for BMI at baseline. BMI during early adulthood was associated with increased pancreatic cancer mortality (HR = 1.18, 95% CI 1.11-1.25 per 5 kg/m(2)), with increased risk observed in both overweight and obese individuals (compared with BMI of 21.0 to <23 kg/m(2), HR = 1.36, 95% CI 1.20-1.55 for BMI 25.0 < 27.5 kg/m(2), HR = 1.48, 95% CI 1.20-1.84 for BMI 27.5 to <30 kg/m(2), HR = 1.43, 95% CI 1.11-1.85 for BMI ≥30 kg/m(2)). BMI gain after early adulthood, adjusted for early adult BMI, was less strongly associated with pancreatic cancer mortality (HR = 1.05, 95% CI 1.01-1.10 per 5 kg/m(2)).Conclusions Our results support an association between pancreatic cancer mortality and central obesity, independent of BMI, and also suggest that being overweight or obese during early adulthood may be important in influencing pancreatic cancer mortality risk later in life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persons who are overweight (>25 kg/m2) or obese (>30 kg/m2) may have an increased risk of a variety of cancers, although risk may be modified by age, sex, race, menopausal status, duration of obesity, anthropomorphic distribution of adiposity, and the presence of additional metabolic syndrome components.1730,1732–1738”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1735]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“but this may be dependent on racial background with increased risk in African American men.1735”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1735]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,269
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
Marmot, M. G., Atinmo, T., Byers, T., Chen, J., Hirohata, T., Jackson, A., James, W., Kolonel, L. N., Kumanyika, S., Leitzmann, C., et al. (2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,368
Cancer incidence, mortality and prevalence worldwide
Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796
International Statistical Classification of Diseases and Related Health Problems
Eisfeld, J. (2014) · TSQ Transgender Studies Quarterly · doi:10.1215/23289252-2399740 · Cited by 3,570
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
Body-mass index and mortality among 1.46 million white adults
Berrington de Gonzalez, A., Hartge, P., Cerhan, J. R., Flint, A. J., Hannan, L., MacInnis, R. J., Moore, S. C., Tobias, G. S., Anton-Culver, H., Freeman, L. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000367 · Cited by 2,317
Self-citationUse and misuse of population attributable fractions
Rockhill, B., Newman, B., & Weinberg, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.1.15 · Cited by 1,683
Childhood Adiposity, Adult Adiposity, and Cardiovascular Risk Factors
Juonala, M., Magnussen, C. G., Berenson, G. S., Venn, A., Burns, T. L., Sabin, M. A., Srinivasan, S. R., Daniels, S. R., Davis, P. H., Chen, W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010112 · Cited by 1,665
Globocan 2000 : cancer incidence, mortality and prevalence worldwide
Ferlay, J., Pisani, P., & Parkin, D. M. (2001) · Medical Entomology and Zoology · Cited by 1,579
Flagged first, then by citations
Research works printed but not linked: 2
- World Cancer Research Fund/American Institute for Cancer Research, 2012, Food, Nutrition, Physical Activity, and the Prevention of Pancreatic Cancer
- Puckett, 1986, The Educational Annotation of ICD-9-CM; Diseases and Procedures Tabular Lists
Cited by
Sorted by citations
Items 101–159 of 159
Could the burden of pancreatic cancer originate in childhood?
Diaconescu, S., Gîlcă-Blanariu, G.-E., Poamaneagra, S. C., Mărginean, O., Păduraru, G., & Ștefănescu, G. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i32.5322 · Cited by 5
Obesity reprograms the normal pancreas and pancreatic cancer microbiome in mice and humans
da Cruz, R. S., Suguru, S., Paiva, S. P. C., Nwugwo, I., Kallakury, B., Weinberg, B. A., Cook, K. L., & de Assis, S. (2025) · Frontiers in Microbiomes · doi:10.3389/frmbi.2025.1543144 · Cited by 4
Chen, J.-C., Huang, T.-H., Wei, T.-C., Huang, I.-S., Fan, Y., Lin, C., Lin, T., Chung, H., Lu, S., Kuo, J.-Y., et al. (2023) · World Journal of Urology · doi:10.1007/s00345-023-04685-5 · Cited by 4
Diet-induced obesity does not exacerbate cachexia in male mice bearing Lewis-lung carcinoma tumors
Beaudry, A. G., Law, M. L., Gilley, K., Buley, H., Dungan, C. M., Nascimento, C. M. C., Vichaya, E. G., & Wiggs, M. P. (2024) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00208.2023 · Cited by 5
Tang, Z., Xu, W., & Zhang, M. (2022) · PeerJ · doi:10.7717/peerj.14538 · Cited by 4
Epidemiology of Cardio-Oncology
Lenneman, C. G., Kimmick, G. G., & Sawyer, D. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-43096-6_1 · Cited by 4
Ghosh, A., & Misra, A. (2026) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2026.103389 · Cited by 3
Hu, M., Li, M.-D., Lin, Y., Pei, J., Yao, Q., Jiang, L., Jin, Y., Tian, Y., & Zhu, C. (2024) · International Journal of Cancer · doi:10.1002/ijc.35082 · Cited by 3
A Call to Action-The Need to Address Obesity in the Black Community
Earles, K., Ard, J. D., & Stanford, F. C. (2020) · Journal of the National Medical Association · doi:10.1016/j.jnma.2020.03.006 · Cited by 3
Racial and Gender Disparities Among Obese Patients With Pancreatic Cancer
Twohig, P. A., Butt, M., Gardner, T. B., Chahal, P., & Sandhu, D. S. (2022) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001688 · Cited by 3
Factors influencing mortality trends of pancreatic cancer in Spain, 1955-2020
Ortiz, E. G. (2022) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2022.8559/2021 · Cited by 3
Lai, Z., Liu, Z., Wang, X., Jiang, X., Yang, Y., Fan, X., Shi, Y., & Li, X. (2025) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2025.20 · Cited by 3
Wang, X., Zhou, G., Zeng, J., Yang, T., Chen, J., & Li, T. (2018) · Public Health · doi:10.1016/j.puhe.2018.04.013 · Cited by 3
RetractedCholesterol deprivation induces TGFβ signaling to promote basal differentiation in pancreatic cancerPreprint
Gabitova-Cornell, L., Peri, S., Restifo, D., Klochkova, A., Hartman, T. R., O’Reilly, A. M., Francescone, R. A., III, Franco‐Barraza, J., Shah, N., Nicolas, É., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/633719 · Cited by 3
Prevention of Early-Onset Colorectal Cancer: Not One Size Fits All
Otegbeye, E. E., Colditz, G. A., & Cao, Y. (2021) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkab030 · Cited by 3
Chen, R., & Wei, J. (2025) · Cancer Control · doi:10.1177/10732748251372674 · Cited by 2
Pancreatic tumors: diagnostics and treatment (literature review)
Алиев, И. И., Ivlev, D. A., & Berdinskikh, A. (2020) · Practical oncology · doi:10.31917/2103153 · Cited by 2
Primary and Secondary Prevention of Pancreatic Cancer
Yu, A., Romero, T., & Genkinger, J. M. (2019) · Current Epidemiology Reports · doi:10.1007/s40471-019-00189-2 · Cited by 2
Self-citationГригорьева, И. Н., Efimova, O., & Станиславовна, С. Т. (2020) · Obesity and metabolism · doi:10.14341/omet12329 · Cited by 2
Lipotoxicity as a Barrier for T Cell-Based Therapies
Loschinski, R., Saborido, J. R., Böttcher, M., Kahlfuß, S., & Mougiakakos, D. (2022) · Biomolecules · doi:10.3390/biom12091182 · Cited by 2
Sinir, G. Ö., İnan, S., Suna, S., Tamer, C. E., Akgül, M. B., Bağdaş, D., Sönmez, G., Evrensel, T., Kaya, E., Sarandöl, E., et al. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1770811 · Cited by 2
Schwalb, M. E., Smith‐Warner, S. A., Hou, J. Y., Rohan, T. E., Snetselaar, L. G., Luo, J., & Genkinger, J. M. (2022) · American Journal of Epidemiology · doi:10.1093/aje/kwac016 · Cited by 2
Self-citationDiet, inflammation, and cancer
Chumanevich, A. A., Hébert, J. R., Spicer, M., & Hofseth, L. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822130-3.00016-8 · Cited by 1
The role of obesity in mortality from digestive diseases in UK Biobank
Wang, C., Zhang, X., Wang, P., Yang, X., Yu, H., Xu, W., Chen, L., & Mu, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-75787-2 · Cited by 1
Saha, A., Rahman, I., Roy, A., Azad, N., Biswas, P., Usha, A. T., Chowdhury, A. F. M. D. N., & Ferdoush, J. (2024) · Human Gene · doi:10.1016/j.humgen.2024.201371 · Cited by 1
Makkai-Popa, S. T., Vito, D. B., Alexandru, M. M., Arru, L., Martine, G., & Santiago, A. J. (2025) · Case Reports in Surgery · doi:10.1155/cris/9982214 · Cited by 1
Peila, R., Manson, J. E., & Rohan, T. E. (2025) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-25-0745 · Cited by 1
Li, K., Zhang, C., & Yan, C. (2025) · The FASEB Journal · doi:10.1096/fj.202501757r · Cited by 1
Sánchez-García, J., Candanedo-González, F., Félix-Félix, A. K., Sánchez-Ramírez, D., Guzman, R. M., Quintana-Quintana, M., Baas-Cabrera, Y. B., & Figueroa, E. F. (2018) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2018.04.002 · Cited by 1
Risk Factors for Pancreatic Cancer
Franklin, O., & Sund, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-53786-9_1 · Cited by 1
Clinical History and Risk Factors of Pancreatic Cancer
Hüser, N., Aßfalg, V., & Frieß, H. (2018) · doi:10.1002/9781119188421.ch94 · Cited by 1
Ductal Adenocarcinoma and Variants
Karamitopoulou-Diamantis, E. (2022) · Encyclopedia of pathology · doi:10.1007/978-3-030-62416-3_5538 · Cited by 1
Facteurs prédisposants de l’adénocarcinome pancréatique : quel est le rôle de l’imagerie ?
Vullierme, M., & Lagadec, M. (2016) · Journal de radiologie diagnostique et interventionnelle · doi:10.1016/j.jradio.2016.10.003
Naffouje, S. A., & Salti, G. I. (2018) · Springer eBooks · doi:10.1007/978-3-319-93545-4_40
Effects of Resistance Exercise on Postprandial Metabolism in Obese Men with Prediabetes
Bittel, A. J. (2018) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/tdvz-6g03
Cancer Alternative Medicine and Cancer Prevention Research
Chang, A. I., Schwertschkow, A., Greenlee, H., Larkey, L., Bloom-Foster, J., & Mehl‐Madrona, L. (2019) · Springer eBooks · doi:10.1007/978-3-030-15935-1_9
Genetic manipulations with chemotherapy in pancreatic cancer
Tillu, H., & Bramhachari, P. V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819457-7.00007-4
Pancreatic Ductal Adenocarcinoma and Type 2 Diabetes Mellitus: Distant Relatives or the Close Ones?
Subham, K., Mohanty, S., Jena, S., Ojha, M., & Jha, S. (2020) · Diagnostics and therapeutic advances in GI malignancies · doi:10.1007/978-981-15-5471-1_13
Inflammation and Its Role in Obesity-Related Complications
Singh, M. M., Sharma, J. R., Agraval, H., & Yadav, U. C. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_10
Schäfer, D. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8485
Obesity and Biliopancreatic Cancers: Exploring Current Evidence
Saâdi, H. (2021) · RA Journal Of Applied Research · doi:10.47191/rajar/v7i9.05
Roshni, S., Lijeesh, A., Jose, J. H. J., & Mathew, A. (2021) · EMJ Oncology · doi:10.33590/emjoncol/21-00018
OBESITY AND ITS RELATIONSHIP WITH CANCER: PART I OBESITY
Agarwal, S. K. (2021) · American International Journal of Cancer Studies · doi:10.46545/aijcs.v3i1.214
Ductal Adenocarcinoma and Variants
Karamitopoulou, E. (2022) · Encyclopedia of pathology · doi:10.1007/978-3-319-28845-1_5538-1
Identifying Clinical Detection in Disease Context by Computational Mining of PubMed
Fu, X., & Zhou, Y. (2021) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1865/4/042119
New and future prospects of obesity and cancer
Davis, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90965-5.00003-9
Cazacu, I. M., Singh, B. S., McAllister, F. M., Săftoiu, A., & Bhutani, M. S. (2022) · Springer eBooks · doi:10.1007/978-3-031-05724-3_4
Lu, B., Cai, J., Chen, H., Lu, M., Zhang, Y., Luo, C., You, L., Dai, M., & Zhao, Y. (2023) · doi:10.2196/preprints.45500
Obesity and Pancreatic Cancer: Its Role in Oncogenesis
Vobugari, N., & Sun, K. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110216
Clinical History and Risk Factors of Pancreatic Cancer
Hüser, N., Aßfalg, V., & Frieß, H. (2023) · doi:10.1002/9781119876007.ch127
Fan, L., Iona, A., Feng, S., Zhou, G., Sun, H., Yao, P., Yu, C., Chen, Y., Sun, D. J. Y., Pei, P., et al. (2026) · 中国科学通报：英文版 · doi:10.1016/j.scib.2026.02.036
Self-citationIL-1β Signaling, Obesity, and Venous Thromboembolism: A Mendelian Randomization Study
Sun, B., Gao, L., Wang, G., Wang, Y., Gao, X., Fan, Y., Jia, R., Wu, Z., Wang, C., Gao, Y., et al. (2026) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2026.02.038
Gouirand, V. (2018) · theses.fr (ABES) · doi:10.70675/fff49f3ezaf3bz4eaaz80f7z7dd647ad95a1
Exploring PI3K signalling dynamics in pancreatic cancer
Delgado, C. F. R. (2020) · theses.fr (ABES) · doi:10.70675/6df9a059zc3f1z4997z9de2z34a1d24dfbeb
Aspartame Increases the Risk of Pancreatic Ductal Adenocarcinoma
Xie, J., Fang, W., Song, Z., Yu, Z., Zhu, Y., & Liu, S. (2026) · eFood · doi:10.1002/efd2.70160 · Cited by 1
Catani, G., Juez, L. D., O’Connor, J. M., Spinelli, A., & Perea, J. (2026) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2026.2690189
Metadata
- Authors
- Genkinger, J. M., Kitahara, C. M., Bernstein, L., Berrington de Gonzalez, A., Brotzman, M., Elena, J. W., Giles, G. G., Hartge, P., Singh, P. N., Stolzenberg-Solomon, R. Z., Weiderpass, E., Adami, H.-O., Anderson, K. E., Beane-Freeman, L. E., Buring, J. E., Fraser, G. E., Fuchs, C. S., Gapstur, S. M., Gaziano, J. M., Helzlsouer, K. J., Lacey, J. V., Linet, M. S., Liu, J. J., Park, Y., Peters, U., Purdue, M. P., Robien, K., Schairer, C., Sesso, H. D., Visvanathan, K., White, E., Wolk, A., Wolpin, B. M., Zeleniuch-Jacquotte, A., & Jacobs, E. J.
- Affiliations
- Columbia University Irving Medical Center (US)
- National Cancer Institute (US)
- City Of Hope National Medical Center (US)
- Westat (United States) (US)
- United States Department of Health and Human Services (US)
- The University of Melbourne (AU)
- Loma Linda University Medical Center (US)
- Karolinska Institutet (SE)
- Harvard University (US)
- University of Minnesota (US)
- Brigham and Women's Hospital (US)
- American Cancer Society (US)
- Mercy Medical Center (US)
- University of Washington (US)
- George Washington University (US)
- Johns Hopkins University (US)
- Corresponding author
- Genkinger, J.M.
- ORCID
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 26
- Issue
- 11
- Pages
- 2257-2266
- ISSN
- 0923-7534 (ISSN-L)
- PMC
- PMC4621029
- OpenAlex
- W2119625192
- Cited by
- 159
- References
- 63
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 10 · 2023: 6 · 2022: 27 · 2021: 19 · 2020: 18 · 2019: 23 · 2018: 14 · 2017: 19 · 2016: 7
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Annals of Oncology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (Z99 CA999999, R01- HL26210, Z01 P010119, CA 77398, R01 CA105069, CA105069, R01 CA39742)
- NIH
- National Institutes of Health (R01-CA14703, K05 CA154337)
- National Heart, Lung and Blood Institute
- National Institute of Environmental Health Sciences (Z01 ES 049030-11, CA 97193, CA 34944, CA 40360, HL 26490, HL 34595)
- American Cancer Society
- National Institute of Aging (5U01AG018033, U01 AG18033)
- Maryland Cancer Registry, Center for Cancer Surveillance and Control
- Maryland Cigarette Restitution Fund
- Centers for Disease Control and Prevention
- Swedish Research Council
- Swedish Council for Working Life and Social Research
- Swedish Cancer Foundation
- NCI (P01 CA055075, UM1 CA167552, UM1 CA186107, P01 CA87969, R01 CA49449, R01 CA 098661, CA 016087)
- Cancer Council Victoria
- Australian NHMRC (209057, 251533, 396414, 504715)
- the National Cancer Institute (ES 000260)
- Swedish Research Council, Swedish Council for Working Life and Social Research
- National Cancer Institute and Office of Dietary Supplements (CA047988, HL043851, HL080467)
- Swedish Cancer Society
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- pancreatic cancer mortality, abdominal obesity, waist-to-hip ratio, waist circumference, body mass index, early adulthood, childhood obesity, weight gain, BMI change, obesity, overweight, cancer risk factors, pooled cohort analysis
- MeSH terms
- Adolescent, Humans, Obesity, Pancreatic Neoplasms, Risk Factors, Cohort Studies, Waist Circumference, Young Adult, Obesity, Abdominal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
